An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.
Several experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on the social media company, the service has taken down problematic material and prohibited associated keywords and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or administering at home.
After minutes of joining one community, a seller shared WhatsApp details, where most transactions occur. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Details and Costs
Within these groups, messages display dark colored packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When asked how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A representative for Telegram said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious health risks”.
